Is CATALYST PHARMACEUTICALS, INC. (CPRX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.1% / 30% | 23.8% / 30% | 4.3% / 30% | 0.17% / 5% | ✓ HALAL |
| DJIM | 0.1% / 33% | 23.8% / 33% | 4.3% / 33% | 0.17% / 5% | ✓ HALAL |
| MSCI | 0.3% / 33% | 64.2% / 33% | 11.6% / 33% | 0.17% / 5% | ✗ NOT HALAL |
| S&P | 0.1% / 33% | 23.8% / 33% | 4.3% / 33% | 0.17% / 5% | ✓ HALAL |
| FTSE | 0.3% / 33% | 64.2% / 33% | 11.6% / 50% | 0.17% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 83.0% | |
| Operating Margin | 40.5% | |
| Net Margin | 36.4% | |
| Return on Equity (ROE) | 25.5% | |
| Return on Assets (ROA) | 16.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $209M |
| Free Cash Flow | $209M |
| Total Debt | $3M |
| Debt-to-Equity | 0.3 |
| Current Ratio | 6.1 |
| Total Assets | $1.1B |
Price & Trading
| Last Close | $24.25 |
| 50-Day MA | $23.99 |
| 200-Day MA | $22.22 |
| Avg Volume | 1.2M |
| Beta | 0.7 |
|
52-Week Range
$19.05
| |
About CATALYST PHARMACEUTICALS, INC. (CPRX)
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Purification Calculator
As a halal stock with 0.17% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is CATALYST PHARMACEUTICALS, INC. (CPRX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), CATALYST PHARMACEUTICALS, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is CATALYST PHARMACEUTICALS, INC.'s debt ratio?
CATALYST PHARMACEUTICALS, INC.'s debt ratio is 0.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.3%.
Does CATALYST PHARMACEUTICALS, INC. require dividend purification?
Yes, CATALYST PHARMACEUTICALS, INC. has an impermissible income ratio of 0.17%, which means 0.17% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are CATALYST PHARMACEUTICALS, INC.'s key financial metrics?
CATALYST PHARMACEUTICALS, INC. has a market capitalization of $2.9B, trailing P/E ratio of 13.9, and revenue of $589M. The company maintains a gross margin of 83.0% and a net margin of 36.4%. Return on equity stands at 25.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.